Intelence (Etravirine, TMC125)
| Brand Name: |
Intelence |
| Generic Name: |
Etravirine, TMC125 |
| Adult Single Dose: |
One 200-mg tablet or two 100-mg tablets (twice a day) |
| Food & Liquid Restrictions: |
Take after a meal
|
| Drug Class: |
NNRTI |
|
|
|
 |
| Click here for a summary of the essential details on Intelence (etravirine, TMC125) from Cal Cohen, M.D. |
|
The Basics
- Patient Information About Intelence (TMC125, Etravirine) (PDF) (February 2013)
From Tibotec Therapeutics
- An Overview of Intelence (TMC125, Etravirine) (September 13, 2012)
From AIDSinfo
- Etravirine (Intelence) (March 28, 2012)
To read PDF, click here.
From AIDS InfoNet
- Intelence (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FAQs About Intelence (Etravirine) (January 3, 2012)
From The Body's "Ask the Experts" Forums
- HIV/AIDS Update -- New Intelence Labeling: Severe Skin and Hypersensitivity Reactions (August 2009)
Important drug warning.
To read PDF, click here.
From Tibotec Therapeutics
- Drug Watch: Next-Generation NNRTIs: Etravirine and Rilpivirine (Winter 2008)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- News Analysis: U.S. Approval of Intelence (Etravirine) (January 25, 2008)
An interview with Cal Cohen, M.D., M.S.
From TheBody.com
- Project Inform Welcomes Approval and Pricing of Intelence, Calls for Further Research (January 23, 2008)
From Project Inform
- Intelence (TMC125, Etravirine) Approved in United States (January 19, 2008)
From U.S. Food and Drug Administration
- Intelence (Etravirine) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
News & Research
- Intelence (Etravirine) Labeling Updates (March 1, 2013)
From U.S. Food and Drug Administration
- Darunavir/Ritonavir and Etravirine as a Prevention Method Is Biologically Plausible (Summer 2012)
To read PDF, click here.
In Being Alive Newsletter, from Being Alive
On TheBodyPRO.com
- Intelence Now for Kids Ages 6 and Older (May/June 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Intelence (Etravirine): Pediatric Dosing Recommendations and New Scored 25 mg Tablet for Pediatric Dosing (March 26, 2012)
From U.S. Food and Drug Administration
- Etravirine 200-mg Formulation Available in UK (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Paediatric Antiretroviral Pipeline: Update on Etravirine and Maraviroc (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Etravirine Lowers Levels of Maraviroc Given at 300 or 600 mg Twice Daily (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- MSF Letter Criticizes Johnson & Johnson for Not Joining Medicines Patent Pool (April 26, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Newly Approved Intelence (Etravirine) Dose May Halve Pill Burden (December 23, 2010)
From U.S. Food and Drug Administration
- Switch From Sustiva to Intelence Reduces Central Nervous System Side Effects (July 20, 2010)
From AIDSmeds.com
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
